Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Kymera Therapeutics Inc., 3 years.
Kymera Therapeutics Inc.
Director
Liquidia Corporation
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 16, 2026 | Liquidia Corporation | Grant or award | +5,882 | — | — |
| Aug 19, 2025 | Liquidia Corporation | Open-market sale | −5,000 | $27.17 | $135,850 |
| Jun 17, 2025 | Liquidia Corporation | Grant or award | +18,396 | — | — |
| Jun 20, 2024 | Liquidia Corporation | Grant or award | +20,359 | — | — |
| Jun 7, 2024 | Kymera Therapeutics Inc. | Option exercise | +8,500 | $2.08 | $17,680 |
| Jun 7, 2024 | Kymera Therapeutics Inc. | Open-market sale | −2,187 | $32.65 | $71,406 |
| Jun 7, 2024 | Kymera Therapeutics Inc. | Open-market sale | −6,313 | $33.11 | $209,023 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.